Karuna Therapeutics (KRTX)
US Market

Karuna Therapeutics (KRTX) Financial Statements


Karuna Therapeutics Financial Overview

Karuna Therapeutics's market cap is currently ―. The company's EPS TTM is $-11.726; its P/E ratio is -28.13; Karuna Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-2.73. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue-$ 147.00K$ 147.00K$ 147.00K$ 81.00K
Gross Profit-$ 147.00K$ 147.00K$ 147.00K-
EBIT$ -119.12M$ -103.16M$ -97.57M$ -84.89M$ -80.99M
EBITDA$ -129.57M$ -112.05M$ -104.55M$ -89.26M$ -80.70M
Net Income Common Stockholders$ -119.12M$ -103.16M$ -97.57M$ -76.19M$ -76.96M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.34B$ 1.44B$ 1.47B$ 1.12B$ 1.19B
Total Assets$ 1.39B$ 1.47B$ 1.51B$ 1.16B$ 1.23B
Total Debt$ 15.61M$ 15.81M$ 4.76M$ 5.33M$ 5.89M
Net Debt$ -1.33B$ -1.42B$ -1.47B$ -1.12B$ -1.19B
Total Liabilities$ 62.78M$ 48.90M$ 26.42M$ 1.16B$ 44.46M
Stockholders Equity$ 1.32B$ 1.42B$ 1.49B$ 1.13B$ 1.18B
Cash Flow-
Free Cash Flow$ -110.63M$ -64.91M$ -101.34M$ -79.05M$ -60.12M
Operating Cash Flow$ -110.00M$ -64.13M$ -100.63M$ -78.76M$ -59.95M
Investing Cash Flow$ 28.31M$ -253.58M$ -27.49M$ -306.62M$ -292.02M
Financing Cash Flow$ 2.66M$ 18.40M$ 442.45M$ 5.38M$ 844.19M
Currency in USD

Karuna Therapeutics Earnings and Revenue History

Karuna Therapeutics Debt to Assets

Karuna Therapeutics Cash Flow

Karuna Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis